339 related articles for article (PubMed ID: 22147974)
1. Liver transplantation for hepatocellular carcinoma on cirrhosis: strategies to avoid tumor recurrence.
Vivarelli M; Risaliti A
World J Gastroenterol; 2011 Nov; 17(43):4741-6. PubMed ID: 22147974
[TBL] [Abstract][Full Text] [Related]
2. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
[TBL] [Abstract][Full Text] [Related]
3. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
4. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V
Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611
[TBL] [Abstract][Full Text] [Related]
5. Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation.
Wang MX; Chen D; Zhao YY; Yang B; Jiang JP; Zeng FJ; Wei L; Chen ZS
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):378-383. PubMed ID: 32622825
[TBL] [Abstract][Full Text] [Related]
6. Strategies of immunosuppression for liver transplant recipients with hepatocellular carcinoma.
Castroagudín JF; Molina-Pérez E; Ferreiro-Iglesias R; Varo-Pérez E
Transplant Proc; 2011 Apr; 43(3):711-3. PubMed ID: 21486580
[TBL] [Abstract][Full Text] [Related]
7. The Importance of the Immunosuppressive Regime on Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Yilmaz S; Ince V
J Gastrointest Cancer; 2021 Dec; 52(4):1350-1355. PubMed ID: 34611833
[TBL] [Abstract][Full Text] [Related]
8. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation for hepatocellular carcinoma: an update.
Zarrinpar A; Kaldas F; Busuttil RW
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):234-42. PubMed ID: 21669564
[TBL] [Abstract][Full Text] [Related]
11. Current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation.
Wang ZY; Geng L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):145-9. PubMed ID: 25865686
[TBL] [Abstract][Full Text] [Related]
12. [Liver transplantation for hepatocellular carcinoma].
Suh KS; Yi NJ
Korean J Hepatol; 2006 Dec; 12(4):493-506. PubMed ID: 17237627
[TBL] [Abstract][Full Text] [Related]
13. Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series.
Ferreiro AO; Vazquez-Millán MA; López FS; Gutiérrez MG; Diaz SP; Patiño MJ
Transplant Proc; 2014 Dec; 46(10):3496-501. PubMed ID: 25498079
[TBL] [Abstract][Full Text] [Related]
14. Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience.
Zhou J; Fan J; Wang Z; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Sun J; Xiao YS; He YF; Wang YQ; Tang ZY
World J Gastroenterol; 2006 May; 12(19):3114-8. PubMed ID: 16718799
[TBL] [Abstract][Full Text] [Related]
15. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.
Rodríguez-Perálvarez M; Tsochatzis E; Naveas MC; Pieri G; García-Caparrós C; O'Beirne J; Poyato-González A; Ferrín-Sánchez G; Montero-Álvarez JL; Patch D; Thorburn D; Briceño J; De la Mata M; Burroughs AK
J Hepatol; 2013 Dec; 59(6):1193-9. PubMed ID: 23867318
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
17. [Liver transplantation for hepatocellular carcinoma. Mid-term results].
Gugenheim J; Crafa F; Fabiani P; Saint-Paul MC; Goubaux B; Ouzan D; Mouiel J
Presse Med; 1992 Nov; 21(39):1846-8. PubMed ID: 1337383
[TBL] [Abstract][Full Text] [Related]
18. [Insight and judgment on recurrence of hepatocellular carcinoma after liver transplantation].
Zheng H; Zhang HM; Zheng WP
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):88-92. PubMed ID: 29804372
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for malignant diseases: selection and pattern of recurrence.
Margarit C; Charco R; Hidalgo E; Allende H; Castells L; Bilbao I
World J Surg; 2002 Feb; 26(2):257-63. PubMed ID: 11865357
[TBL] [Abstract][Full Text] [Related]
20. Surgical resection and liver transplantation for hepatocellular carcinoma.
Akoad ME; Pomfret EA
Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]